However, panelists at recent LSRE conference in San Diego remain bullish on the space
By John B. Mugford
SAN DIEGO – For the past decade or so, the life sciences real estate (LSRE) sector has been a “magical” space for facility owners.
That’s because the LSRE sector – which primarily includes office/lab space, but also encompasses research and development (R&D) space, manufacturing space and more – has seen “10 percent a year compounding annual rent growth in many markets,” said Brian Newman, senior VP and portfolio manager with Ventas Inc. (NYSE: VTR).
Ventas, a Chicago-based real estate investment trust and one of the healthcare real estate (HRE) sector’s largest landlords, has in recent years also become a “top 10” owner of life sciences properties.
For LSRE owners like Ventas, during these “magical” years, “you had these smaller tenants in place, and whether they survived and grew and got bigger, or they just collapsed and disappeared, you (could still) refill them with the next generation of startups, (which really helped) increase your NOI (net operating income) way above inflation rates,” Mr. Newman explained.
The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE